Evidence map›Paper›PMID 17486062›Full record

ArticleOncogene2007

Reprogramming of the SWI/SNF complex for co-activation or co-repression in prohibitin-mediated estrogen receptor regulation.

B Zhang, K J Chambers, D V Faller, S Wang

Abstract readComparative Study
PubMed Publisher
In one paragraph

Article in Oncogene, 2007. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 39 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
39citing papers in PubMed, 1 pooled it
3.1field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

39 citing papers in PubMed, 1 synthesis or guideline pooled it, 68 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Article
  4. TGFB2-AS1 inhibits triple-negative breast cancer progression via interaction with SMARCA4 and regulating its targetsProceedings of the National Academy of Sciences of the United States of America · 2022
    Article
  5. Article
  6. Article
  7. Review
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

B ZhangCancer Research Center, Boston University School of Medicine, Boston, MA 02118, USA.
K J Chambers
D V Faller
S Wang
Boston University · USCancer Research Center · US

Funding

Signal Transduction by Androgen in Prostate CellsR01CA101992 · NCI · BOSTON UNIVERSITY MEDICAL CAMPUS · PI FALLER, DOUGLAS V · 2004 to 2013
$2.4M
Role of Prohibitin in Mediating Suppression of Breast Cancer Growth by Estrogen *R03CA102940 · NCI · BOSTON UNIVERSITY MEDICAL CAMPUS · PI WANG, SHENG · 2003 to 2004
$162k
NCI NIH HHS 1R03CA102940-01NCI NIH HHS CA101992
6 · The paper itself

Abstract

The SWI/SNF complex participates as a co-activator in the transcriptional regulation of certain genes. Conversely, we and others have recently established that Brg1 and Brm, the central components of SWI/SNF, act instead as co-repressors for E2F-mediated transcriptional repression, and for the transcription of certain other promoters. We report here that Brg-1 and Brm can switch their mode of function at same promoter between activation and repression by ligand-directed differential coordination with BAF155, BAF170, HDAC1, p300 and prohibitin. This ligand and context-dependent reprogramming of the SWI/SNF complex allows it to differentially serve as either a co-repressor or a co-activator of transcription at the same promoter.

Indexed as

Cell Line, TumorChromosomal Proteins, Non-HistoneDNA-Binding ProteinsDNA HelicasesEstrogensGene Expression RegulationHumansLigandsNuclear ProteinsProhibitinsReceptors, EstrogenRepressor ProteinsTrans-ActivatorsTranscription FactorsTumor Suppressor ProteinsChromosomal Proteins, Non-HistoneDNA-Binding ProteinsDNA HelicasesEstrogensLigandsNuclear ProteinsProhibitinsReceptors, EstrogenRepressor ProteinsSMARCA2 protein, humanSMARCA4 protein, humanSMARCC1 protein, humanSMARCC2 protein, humanSWI-SNF-B chromatin-remodeling complexTrans-ActivatorsTranscription FactorsTumor Suppressor Proteins

Identifiers

PMID17486062
OpenAlexW2053443724

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.